Catalogue identityPreview · noindex

Profhilo Structura

IBSA

This is the Profhilo Structura identity captured in the dated Aesthetic Pass operational catalogue snapshot. Product-specific source verification is available at family level only.

Evidence status: Catalogue identity · family sources available

Identity record

What is recorded

v2026.08.15.1
Record type
Operational catalogue identity
Recorded maker
IBSA
Classification
Skin booster / biostimulator
Material identity
Not recorded in this snapshot
Snapshot date
15 August 2026

Manufacturer and category are catalogue fields. They are not, by themselves, a regulatory classification or verification of the exact marketed presentation.

Family evidence available

This identity maps to Profhilo

The family profile provides aliases and official family-level sources. Those sources do not automatically verify this exact variant, formulation, label, or market status.

Open family profile

Provenance

Family-level sources

4 sources · checked 15 August 2026

These sources support the linked family profile, not every property of this exact catalogue identity.

  1. Manufacturer

    1. Profhilo product line

    IBSA Derma · International overview

    Open source ↗

    Supports: Profhilo family identity and hyaluronic-acid material class.

  2. Manufacturer

    2. Profhilo — Face & Neck

    IBSA Germany · Germany

    Open source ↗

    Supports: German manufacturer product listing and local product-information context.

  3. Regulator

    3. PROFHILO 3.2% — ARTG 387132

    Australian Therapeutic Goods Administration · Australia

    Open source ↗

    Supports: The active Australian Class III medical-device record for the named PROFHILO 3.2%, 32 mg H-HA plus 32 mg L-HA per 2 ml presentation and its manufacturer.

  4. Instructions for use

    4. Profhilo — Australian Instructions for Use

    IBSA Farmaceutici Italia / IBSA Derma Australia · Australia

    Open source ↗

    Supports: The product-specific Profhilo identity, 2 ml presentation, sodium-hyaluronate composition, professional-use context, precautions, and adverse-event wording for the attached Australian IFU.

Use boundary

What this record does not establish

  • Regulatory statusOnly within a source's named jurisdiction; family-profile review does not establish status elsewhere.
  • Authenticity or supply chainA catalogue name cannot authenticate an individual box, lot, or seller.
  • Clinical suitabilityNo product selection, patient assessment, dose, protocol, or injection technique is provided.
  • Availability or equivalenceNames, formulations, units, and presentations can vary by market and over time.

Separate reference from record-keeping

Document the exact product and lot actually used

Aesthetic Pass records treatment identity, lot information, photos, and injection maps. The atlas itself never chooses a product or treatment.

Explore traceability